ReposiTrak (TRAK) Liabilities and Shareholders Equity (2011 - 2025)

ReposiTrak's Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $56.3 million for Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity rose 2.88% year-over-year to $56.3 million in Q4 2025; TTM through Dec 2025 was $222.1 million, a 5.76% increase from a year earlier, with the FY2025 full-year figure at $55.3 million, up 7.23% from the prior year.
• Liabilities and Shareholders Equity improved to $56.3 million in Q4 2025 per TRAK's latest filing, from $55.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $56.3 million in Q4 2025 and bottomed at $48.8 million in Q4 2022.
• The 5-year median for Liabilities and Shareholders Equity is $51.0 million (2023), against an average of $52.1 million.
• Across the five-year window, Liabilities and Shareholders Equity declined 11.66% in 2022 and advanced 8.76% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $50.3 million in 2021, then retreated by 2.86% to $48.8 million in 2022, then advanced by 3.03% to $50.3 million in 2023, then grew by 8.76% to $54.7 million in 2024, then advanced by 2.88% to $56.3 million in 2025.
• Per Business Quant, the three latest TRAK Liabilities and Shareholders Equity figures stand at $56.3 million (Q4 2025), $55.6 million (Q3 2025), and $55.3 million (Q2 2025).